Value through Innovation04 February 2016

From Curiosity to Discovery - The Research & Development Process

Boehringer Ingelheim seeks to help people by researching diseases and developing new medicines and therapies. Our vision "Value through Innovation" is the driver of drug discovery in our worldwide research & development sites. In addition to the development of prominent substances from own research into the treatment of cardiovascular, central nervous system, respiratory, urological and virological disorders, we have successfully advanced our research in oncological, metabolic and thromboembolic diseases.

Drug Discovery

  • Drug Discovery Process

    From the initial discovery to a marketable medicine is a long, challenging road. It takes around 12 years to discover and develop a new drug.

  • Pipeline

    The Boehringer Ingelheim pipeline is currently well-filled with innovative compounds from our own research.

Research Areas

Research Areas

Our drug discovery focuses on seven major therapeutic areas.

Centres and Technologies

Research Centres

We maintain R&D sites, support centres and Global Skill Centres.